Lupin
- All
- News
- Videos
-
Lupin's December Quarter Profit Declines 72% To Rs 153 Crore
Lupin had reported a net profit of Rs 545 crore for October-December period last fiscal.
-
Lupin Launches Generic Joint Pain Drug In US
Lupin said diclofenac sodium topical solution, 2 per cent, had estimated annual sales of $509 million in the US.
-
Lupin Stock Up 4% On September Quarter Results
Shares of Lupin today climbed 4 per cent after the company reported a profit in the September quarter.
-
International Emmy 2022: Sex Education, Help, Lupin Among Nominees
23 countries are represented across 15 categories and 60 nominees
-
Pharma Firm Lupin Gets US Regulator Nod For Generic Drug To Treat Cancer
Lupin on Monday said it has received a tentative approval from the US health regulator to market Dasatinib tablets, used to treat certain types of cancer, in America.
-
Pharma Firm Lupin Gets US Regulator Nod For Generic Drug To Treat Seizures
Pharmaceuticals firm Lupin Ltd on Thursday said it has received approval from the US health regulator to market its generic rufinamide tablets used in the treatment seizures.
-
Lupin Receives Inspection Report From USFDA For Goa Manufacturing Facility
The USFDA has determined that the inspection classification of the facility is VAI, the company said in a statement.
-
Lupin, Eicher Motors, Bata India Among Stocks In Focus In Muhurat Session
Lupin announced launch of authorized generic version of Antara Fenofibrate capsules, 30 mg and 90 mg
-
Squid Game Is Netflix’s Biggest Series Ever, as 142 Million Viewers Tune In
Squid Game is now Netflix's biggest original series of all time. More than 142 million Netflix households watched Squid Game in the first 28 days after its release.
-
Stocks To Watch: Infosys, Shreyas Shipping, Atul Auto, Lupin
Infosys and SAP have joined hands to drive business innovation with new leads and proposals solution for the professional services industry
-
Lupin Falls After US FDA Inspects Goa Facility With Seven Observations
Lupin shares have so far this year fallen 2.73 per cent, sharply underperforming the benchmark Sensex which has advanced 23.6 per cent.
-
Nifty Seen Opening Below 17,500; Wipro, Lupin In Focus
Market Live Updates: Foreign institutional investors bought shares worth Rs 1,553 crore on Friday while domestic institutional investors sold shares worth Rs 1,398 crore.
-
Lupin Receives Tentative Nod For Anti-Seizure Drug; Stock Edges Higher
"The company (Lupin) has received tentative approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Brivaracetam Tablets," Lupin said
-
Nifty Seen Opening Marginally Lower; Lupin In Focus
Foreign institutional investors sold shares worth Rs 1,088 crore on Monday while domestic institutional investors bought shares worth Rs 506 crore.
-
Stocks To Watch: Infosys, Hero MotoCorp, Lupin
Infosys will make an additional investment of $0.45 million in TidalScale Inc, taking its total investment in the software-defined-server technology startup to $3.45 million
-
Lupin's December Quarter Profit Declines 72% To Rs 153 Crore
Lupin had reported a net profit of Rs 545 crore for October-December period last fiscal.
-
Lupin Launches Generic Joint Pain Drug In US
Lupin said diclofenac sodium topical solution, 2 per cent, had estimated annual sales of $509 million in the US.
-
Lupin Stock Up 4% On September Quarter Results
Shares of Lupin today climbed 4 per cent after the company reported a profit in the September quarter.
-
International Emmy 2022: Sex Education, Help, Lupin Among Nominees
23 countries are represented across 15 categories and 60 nominees
-
Pharma Firm Lupin Gets US Regulator Nod For Generic Drug To Treat Cancer
Lupin on Monday said it has received a tentative approval from the US health regulator to market Dasatinib tablets, used to treat certain types of cancer, in America.
-
Pharma Firm Lupin Gets US Regulator Nod For Generic Drug To Treat Seizures
Pharmaceuticals firm Lupin Ltd on Thursday said it has received approval from the US health regulator to market its generic rufinamide tablets used in the treatment seizures.
-
Lupin Receives Inspection Report From USFDA For Goa Manufacturing Facility
The USFDA has determined that the inspection classification of the facility is VAI, the company said in a statement.
-
Lupin, Eicher Motors, Bata India Among Stocks In Focus In Muhurat Session
Lupin announced launch of authorized generic version of Antara Fenofibrate capsules, 30 mg and 90 mg
-
Squid Game Is Netflix’s Biggest Series Ever, as 142 Million Viewers Tune In
Squid Game is now Netflix's biggest original series of all time. More than 142 million Netflix households watched Squid Game in the first 28 days after its release.
-
Stocks To Watch: Infosys, Shreyas Shipping, Atul Auto, Lupin
Infosys and SAP have joined hands to drive business innovation with new leads and proposals solution for the professional services industry
-
Lupin Falls After US FDA Inspects Goa Facility With Seven Observations
Lupin shares have so far this year fallen 2.73 per cent, sharply underperforming the benchmark Sensex which has advanced 23.6 per cent.
-
Nifty Seen Opening Below 17,500; Wipro, Lupin In Focus
Market Live Updates: Foreign institutional investors bought shares worth Rs 1,553 crore on Friday while domestic institutional investors sold shares worth Rs 1,398 crore.
-
Lupin Receives Tentative Nod For Anti-Seizure Drug; Stock Edges Higher
"The company (Lupin) has received tentative approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Brivaracetam Tablets," Lupin said
-
Nifty Seen Opening Marginally Lower; Lupin In Focus
Foreign institutional investors sold shares worth Rs 1,088 crore on Monday while domestic institutional investors bought shares worth Rs 506 crore.
-
Stocks To Watch: Infosys, Hero MotoCorp, Lupin
Infosys will make an additional investment of $0.45 million in TidalScale Inc, taking its total investment in the software-defined-server technology startup to $3.45 million
